NTII.US Neurobiological Technologies Inc
- Market cap
- USD 2.70K
- P/E
- -
- P/B
- 0.07x
- ROE
- 321.0%
- Dividend yield
- 930,322.10%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2010.
Is NTII.US undervalued?
Graham numberThe Graham number of Neurobiological Technologies Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Neurobiological Technologies Inc fundamental analysis
No fundamental analysis for Neurobiological Technologies Inc yet.
Neurobiological Technologies Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Neurobiological Technologies Inc
Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California.
Full company profileNeurobiological Technologies Inc financial statements
Neurobiological Technologies Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 4.78M | - | 1.98M | 2.79M | 3.10M | 12.3M | 17.7M | 14.8M | 26.4M | 6.03M |
| Gross Profit | 1.05M | - | - | - | - | 12.3M | 17.7M | 14.8M | 26.4M | 6.03M |
| Operating Income | 1.03M | - | - | - | - | -16.4M | -15.6M | -16.7M | 3.68M | 4.45M |
| Net Income | 1.59M | - | - | - | - | -27.8M | -14.1M | -16.3M | 3.12M | 4.94M |
| Balance Sheet | ||||||||||
| Total Assets | 11.5M | 7.67M | 4.81M | 21.4M | 17.5M | 22.5M | 10.9M | 43.2M | 3.25M | 2.58M |
| Total Liabilities | 762K | 1.05M | 565K | 661K | 3.82M | 33.9M | 33.0M | 22.9M | 1.95M | 1.04M |
| Shareholders' Equity | 10.7M | 6.61M | 4.25M | 20.7M | 13.7M | -11.4M | -22.1M | 20.3M | 1.30M | 1.54M |
| Cash & Short-term Investments | 3.63M | 277K | 66.0K | 2.01M | 828K | 9.74M | 5.54M | 27.9M | 2.41M | 1.84M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 1.37M | - | - | - | - | 8.98M | -13.1M | -20.7M | -16.4M | 4.78M |
| Capital Expenditure | 24.0K | 0.00 | 13.0K | 5.00K | 645K | 349K | 66.0K | 11.0K | 2.00K | 0.00 |
| Ratios | ||||||||||
| ROE | 14.8% | - | - | - | - | - | - | -80.5% | 240.0% | 321.0% |
| ROA | 13.9% | - | - | - | - | -123.7% | -129.4% | -37.8% | 96.2% | 191.6% |
| Net Profit Margin | 33.2% | - | - | - | - | -225.6% | -79.9% | -110.6% | 11.9% | 82.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Neurobiological Technologies Inc dividends
Neurobiological Technologies Inc has not paid dividends in the last 10 fiscal years.
Last stock split: 1:7 on Sep 17, 2007.
Who owns Neurobiological Technologies Inc
Ownership data of Neurobiological Technologies Inc is not available yet.
Neurobiological Technologies Inc company profile
- Company name
- Neurobiological Technologies Inc
- Ticker
- NTII.US
- Exchange
- USA Stocks
- Listed since
- Feb 16, 1994
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 4
- Fiscal year end
- June
- Address
- 2000 Powell Street, EmeryVille, CA, United States, 94608
- Phone
- 510 595 6000
- Website
- ntii.com
About Neurobiological Technologies Inc
Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California.
Neurobiological Technologies Inc management
1- Mr. John B. StuppinFounder & Director · born 1934